YORKLEIGH SURGERY(CT) — All Prescriptions & Medications — Page 7
Practice Code: L84022 | CHELTENHAM, GL50 3ED
Showing results 301-350 of 538
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Terbinafine hydrochloride | 50 | 1,470 | £268 | +34.8% ▲ |
| Biphasic insulin lispro | 49 | 245 | £1.5K | +14.1% ▲ |
| Azathioprine | 49 | 5,040 | £106 | -54.8% ▼ |
| Chloramphenicol | 49 | 286 | £207 | -57.2% ▼ |
| Hepatitis A | 49 | 49 | £945 | -35.5% ▼ |
| Hydrocortisone | 48 | 1,054 | £243 | -36.8% ▼ |
| Exemestane | 48 | 1,999 | £360 | +47.7% ▲ |
| 48 | 110 | £515 | +54.8% ▲ | |
| Ondansetron hydrochloride | 46 | 1,846 | £1.8K | -5.2% ▼ |
| Testosterone | 46 | 2,943 | £1.5K | -39.7% ▼ |
| Combined ethinylestradiol 35mcg | 46 | 3,990 | £234 | +269.2% ▲ |
| Tiotropium bromide/olodaterol | 45 | 55 | £1.7K | -26.6% ▼ |
| Terbinafine hydrochloride | 45 | 2,676 | £1.2K | -27.2% ▼ |
| Denosumab | 45 | 45 | £9.6K | +65.4% ▲ |
| 45 | 409 | £1.6K | +193.6% ▲ | |
| 45 | 5,400 | £378 | -47.1% ▼ | |
| 45 | 1,300 | £924 | +36.1% ▲ | |
| Methenamine hippurate | 44 | 3,086 | £848 | -51.6% ▼ |
| Glucose | 44 | 4,715 | £426 | -15.4% ▼ |
| Neomycin sulfate | 44 | 675 | £86 | -25.8% ▼ |
| Benzoyl peroxide and clindamycin phosphate | 44 | 1,830 | £797 | -34.4% ▼ |
| 44 | 45 | £125 | +35.8% ▲ | |
| 44 | 450 | £1.1K | +274.1% ▲ | |
| Desmopressin acetate | 43 | 2,504 | £2.8K | -17.6% ▼ |
| Etonogestrel | 43 | 43 | £3.6K | +48.8% ▲ |
| Mycophenolate mofetil | 43 | 2,632 | £298 | +6.2% ▲ |
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 43 | 27.4K | £423 | +87.6% ▲ |
| 43 | 460 | £1.3K | +32.0% ▲ | |
| Adrenaline | 42 | 86 | £5.0K | -33.4% ▼ |
| Isophane insulin | 42 | 224 | £1.7K | -60.2% ▼ |
| Dorzolamide and timolol | 42 | 675 | £604 | -70.7% ▼ |
| Ursodeoxycholic acid | 41 | 6,576 | £2.0K | -38.1% ▼ |
| Flupentixol decanoate | 41 | 50 | £230 | +156.9% ▲ |
| Glycopyrronium/formoterol | 40 | 52 | £1.6K | +58.1% ▲ |
| Biphasic isophane insulin | 40 | 315 | £1.9K | -64.1% ▼ |
| Cyproterone acetate | 40 | 1,822 | £2.2K | +264.4% ▲ |
| 40 | 4,230 | £5.7K | +88.9% ▲ | |
| Moxonidine | 39 | 2,548 | £341 | -29.9% ▼ |
| Fludrocortisone acetate | 39 | 2,324 | £365 | -63.0% ▼ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 38 | 6,900 | £328 | -78.9% ▼ |
| Fluticasone propionate/azelastine hydrochloride (Nasal) | 38 | 54 | £760 | -66.5% ▼ |
| Betamethasone esters | 38 | 2,620 | £272 | -37.0% ▼ |
| Diclofenac sodium | 38 | 1,950 | £1.4K | +58.6% ▲ |
| Amisulpride | 37 | 1,342 | £1.2K | -47.4% ▼ |
| Latanoprost and timolol | 36 | 280 | £309 | -52.9% ▼ |
| 36 | 2,357 | £838 | -8.7% ▼ | |
| Propantheline bromide | 35 | 6,232 | £5.4K | +169.6% ▲ |
| Naldemedine | 35 | 245 | £351 | +298.5% ▲ |
| Cefalexin | 35 | 581 | £71 | -69.9% ▼ |
| Powder 1.6 kcal/ml milkshake (0913011) | 35 | 10.5K | £572 | -53.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.